Healthcare leaders who shape that future need more than innovation. They need a visible, credible voice that helps the people ...

QuantHealth raised $45 million in Series B funding to expand its AI platform, which simulates clinical trials before they run ...

What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes ...

More than three-quarters of health system and hospital executives plan to expand participation in value-based care (VBC) models over the next two years, up from 57% in 2023. But despite growing ...

Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new ...

The American College of Physicians is urging policymakers to expand access to obesity treatment and healthy foods while investing in prevention and research.

M&A activity is going beyond big pharma acquisitions with Supernus Pharmaceuticals and Indivior Pharmaceuticals reaching a ...

How can a biotech startup raise more than $1 billion over four plus years and say almost nothing publicly along the way? For Treeline Biosciences, the silence was strategic. Out of view of prying eyes ...

Eli Lilly metabolic disorder medication tirzepatide, already approved in type 2 diabetes and weight management, now has early clinical data indicating it can also help patients with a fatty liver ...

Aldeyra Therapeutics’ drug for dry eye disease has been rejected by the FDA, marking the third time in three years the eye drop has failed to clear the agency’s regulatory bar. The FDA decision also ...

Providence announced this week that it wants to sell its health plan, signaling its desire to exit the “payvider” club. Being a payvider — an organization that both provides healthcare services and ...

The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information ...